首页> 中文期刊> 《中国医药导报》 >舒芬太尼术后静脉镇痛在胸外科手术中的应用分析

舒芬太尼术后静脉镇痛在胸外科手术中的应用分析

         

摘要

Objective: To study the application of Sufentanil for postoperative analgesia in thoracic surgery. Methods: 268 cases who had been given thoracic surgery from January 2008 to January 2010, were randomly divided into the Fentanyl group (n=130) and Sufentanil group (n=138), to observe the VAS score, press times, 24 h dose and the occurrence of various side effects. Results: There was significant difference between the Fentanyl group and Sufentanil group (ρ<0.05). The incidence of side effects also had significant difference between the two groups (ρ<0.05). Conclusion: The effect of Sufentanil is precise in postoperative analgesia with less occurrence of side effects, low incidence of respiratory depression, and the patients are quiet and have no drowsiness with low incidence of nausea vomiting.%目的:探讨舒芬太尼术后静脉镇痛在胸外科手术中的应用.方法:随机将2008年1月~2010年1月胸外科开胸手术268例分为芬太尼组130例.舒芬太尼组138例.依据观察指标了解VAS评分、按压次数、24 h药量;了解各种副反应发生情况.结果:两组观察指标比较差异有统计学意义(P<0.05),两组副反应发生率比较差异有统计学意义(P<0.05).结论:舒芬太尼术后静脉镇痛效果确切,副反应发生少,呼吸抑制发生率低,患者安静,无嗜睡,恶心、呕吐发生率低.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号